Trials (2036)
Page 19 of 34.
- Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
- A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
- Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
- Pharmacology of Exenatide in Pediatric Sepsis
- Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
- Basal Plus GLP1-ra on Glycemic Variability in CKD
- A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
- PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Clinical Study of 18F-Exendin-4 in Insulinoma
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
- Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
- Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus
- Probiotic Intervention on Body Weight
- Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
- A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects
- Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
- Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- Semaglutide 2.4 mg in Patients With Poor Weight-loss
- Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes
- Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
- Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
- [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
- Specific Clinical Experience Investigation for Long-term Use of Bydureon.
- Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
- DIALYSIS-TIR Study
- GLP-1s to Enhance Lasting Optimal Weight
- Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic Knee
- Impact GLP-1 Agonists Following Bariatric
- Identifying Potential Effects of Liraglutide on Degenerative Changes
- A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
- Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
- The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
- Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
- Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
- The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
- Cardiovascular Effects of GLP-1 Receptor Activation